Literature DB >> 3459660

Cyclic tetramolecular complexes of monoclonal antibodies: a new type of cross-linking reagent.

P M Lansdorp, R C Aalberse, R Bos, W G Schutter, E F Van Bruggen.   

Abstract

A simple and efficient procedure for the construction of bifunctional molecules is described and their use in a variety of applications documented. This procedure is based on our observation that mouse IgG1 monoclonal antibodies, when mixed with equimolar amounts of a high-affinity rat monoclonal antibody specific for mouse IgG1, yield uniform cyclic tetramolecular complexes each consisting of two mouse and two rat antibodies as shown by gel electrophoresis and electron microscopy. When solutions of two mouse antibodies (e.g. a and b) are mixed prior to the formation of complexes with the rat antibody, stable bispecific (a X b) complexes together with monospecific (a X a and b X b) complexes are obtained. Bispecific complexes prepared in this way were able to efficiently bind peroxidase to cell surface antigens, and to bind red blood cells to selected nucleated cell types present in heterogeneous populations. Tetrameric antibody complexes are more easily prepared than bispecific antibodies or bifunctional antibodies produced by transfection of myelomas with recombinant genes. They also have the advantage that the antigen-binding properties of the bivalent monoclonal antibodies are not compromised. Tetrameric antibody complexes thus represent a powerful new type of cross-linking reagent that may have a wide spectrum of applications in biology and medicine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3459660     DOI: 10.1002/eji.1830160615

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

Review 1.  Bispecific antibody: a tool for diagnosis and treatment of disease.

Authors:  S Songsivilai; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

Review 2.  Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.

Authors:  C H Ford; V J Richardson; V S Reddy
Journal:  Indian J Pediatr       Date:  1990 Jan-Feb       Impact factor: 1.967

3.  Immunoactive two-dimensional self-assembly of monoclonal antibodies in aqueous solution revealed by atomic force microscopy.

Authors:  Shinichiro Ido; Hirokazu Kimiya; Kei Kobayashi; Hiroaki Kominami; Kazumi Matsushige; Hirofumi Yamada
Journal:  Nat Mater       Date:  2014-01-19       Impact factor: 43.841

4.  Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells.

Authors:  Liying Yang; James C Lang; Priya Balasubramanian; Kris R Jatana; David Schuller; Amit Agrawal; Maciej Zborowski; Jeffrey J Chalmers
Journal:  Biotechnol Bioeng       Date:  2009-02-01       Impact factor: 4.530

Review 5.  Telomeres, stem cells, and hematology.

Authors:  Peter M Lansdorp
Journal:  Blood       Date:  2008-02-15       Impact factor: 22.113

6.  Microfluidic, marker-free isolation of circulating tumor cells from blood samples.

Authors:  Nezihi Murat Karabacak; Philipp S Spuhler; Fabio Fachin; Eugene J Lim; Vincent Pai; Emre Ozkumur; Joseph M Martel; Nikola Kojic; Kyle Smith; Pin-i Chen; Jennifer Yang; Henry Hwang; Bailey Morgan; Julie Trautwein; Thomas A Barber; Shannon L Stott; Shyamala Maheswaran; Ravi Kapur; Daniel A Haber; Mehmet Toner
Journal:  Nat Protoc       Date:  2014-02-27       Impact factor: 13.491

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.